Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2013/06/2505:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2505:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2505:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2119:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2101:06Business WireSHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty b...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2101:06Business WireSHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty b...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2005:21PR Newswire (US)Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc.NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2003:03PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals, Inc. -- VNDANASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2001:43Business WireLaw Firm of Wohl & Fruchter LLP Announces Investigation of Vanda Pharmaceuticals, Inc.NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/2001:43Business WireLaw Firm of Wohl & Fruchter LLP Announces Investigation of Vanda Pharmaceuticals, Inc.NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/1808:00PR Newswire (US)Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/1106:25Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/0621:00PR Newswire (US)Positive Findings, Collaborations, and NDA Filings Strengthen Pipelines - Research Report on Clovis Oncology, MannKind, TESAR...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/0610:00PR Newswire (US)Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour DisorderNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/06/0105:00PR Newswire (US)Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/3122:09Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/3119:55PR Newswire (US)Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The ...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/3109:30PR Newswire (US)Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical MeetingsNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/2411:00PR Newswire (US)Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of MarylandNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/1019:57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/0920:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/05/0919:55PR Newswire (US)Vanda Pharmaceuticals Reports First Quarter 2013 ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/04/1820:00PR Newswire (US)Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/04/1808:00PR Newswire (US)Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical OfficerNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/04/0508:00PR Newswire (US)Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/03/2520:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/03/2519:55PR Newswire (US)Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In T...NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/03/1505:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/03/1505:05PR Newswire (US)Vanda Withdraws Its Marketing Authorization Application For Fanaptum™ In The European UnionNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/02/2810:00PR Newswire (US)Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA